A key study from @CHI_Ireland documenting clinical and developmental outcomes after 50years of newborn screening for Classical Galactosaemia. Will be of interest to other countries who are currently screening or considering screening for CGal.
pmc.ncbi.nlm.nih.gov/articles/PMC12…
pmc.ncbi.nlm.nih.gov Clinical and Developmental Outcomes After 50 Years of Newborn Bloodspot Screening for Classical... Classical Galactosaemia (CG) is an inborn error of carbohydrate metabolism. In untreated neonates, CG leads to a multi‐organ toxicity with life‐threatening symptoms. Newborn Screening for CG began in... pmc.ncbi.nlm.nih.gov/articles/PMC12…